FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer

BACKGROUND: Obesity increases breast cancer risk and breast cancer-specific mortality, particularly for people with estrogen receptor (ER)-positive tumors. Body mass index (BMI) is used to define obesity, but it may not be the best predictor of breast cancer risk or prognosis on an individual level....

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo-Castrejon, Marisol, Sankofi, Barbara Mensah, Murguia, Stevi Johnson, Udeme, Abasi-ama, Cen, Hoaning Howard, Xia, Yi Han, Thomas, Nisha S., Berry, William L., Jones, Kenneth L., Richard, Vincent R., Zahedi, Rene P., Borchers, Christoph H., Johnson, James D., Wellberg, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463730/
https://www.ncbi.nlm.nih.gov/pubmed/37608351
http://dx.doi.org/10.1186/s13058-023-01699-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463730/
https://www.ncbi.nlm.nih.gov/pubmed/37608351
http://dx.doi.org/10.1186/s13058-023-01699-0

Ejemplares similares